SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 16, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 2 insiders, $221K total
Actionable Insight • Neutral

The insider selling is routine and immaterial. Monitor next quarterly earnings for any fundamental changes, but this cluster alone does not warrant a directional trade.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$535.67
T+0 close · Jul 16, 2026 · via day close
Latest settled
+2.69%
T+60 · $550.10
Vs SPY
−1.99%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 17 $535.67entry
  2. T+1 · 4mo ago −1.18%α −1.02% · $529.34
  3. T+5 · 4mo ago −1.34%α −0.76% · $528.47
  4. T+20 · 3mo ago −6.71%α −11.16% · $499.73
  5. T+60 · 5w ago +2.69%α −1.99% · $550.10
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Insider selling by CEO Martine Rothblatt and EVP/General Counsel Paul Mahon totaling $8.2M, but representing only 0.036% of UTHR's $22.5B market cap. Sales follow option exercises and are likely for tax withholding and liquidity diversification, consistent with routine insider activity. No bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$8.2M
Insiders
2

Key Facts

  • CEO Martine Rothblatt and EVP/General Counsel Paul Mahon sold shares after exercising stock options in a 7-day window.
  • Total open-market sales of approximately $8.18M, equivalent to 0.036% of market cap.
  • Sales are liquidity-driven and tax-related, not a reflection of deteriorating fundamentals.
  • No 10b5-1 plan indicated; the cluster is small relative to company size and insider holdings.

Financial Impact

Total insider selling of $8.2M, insignificant relative to $22.5B market cap

insider holdings

Risk Factors

  • No material risk; the selling is small and typical for option exercises

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1784278922212

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (10h 17m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 17, 2026